962 Shares in Humana Inc. (NYSE:HUM) Bought by Secure Asset Management LLC

Secure Asset Management LLC purchased a new stake in Humana Inc. (NYSE:HUM) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 962 shares of the insurance provider’s stock, valued at approximately $244,000.

Several other institutional investors and hedge funds also recently made changes to their positions in HUM. International Assets Investment Management LLC lifted its position in shares of Humana by 261,025.1% in the 3rd quarter. International Assets Investment Management LLC now owns 738,984 shares of the insurance provider’s stock worth $2,340,660,000 after purchasing an additional 738,701 shares during the period. FMR LLC raised its stake in Humana by 23.4% during the third quarter. FMR LLC now owns 3,388,859 shares of the insurance provider’s stock worth $1,073,387,000 after buying an additional 643,291 shares during the last quarter. Thrivent Financial for Lutherans lifted its holdings in Humana by 55.6% in the third quarter. Thrivent Financial for Lutherans now owns 600,317 shares of the insurance provider’s stock valued at $190,145,000 after buying an additional 214,535 shares during the period. Pzena Investment Management LLC boosted its position in Humana by 8.1% during the third quarter. Pzena Investment Management LLC now owns 2,506,250 shares of the insurance provider’s stock valued at $793,830,000 after acquiring an additional 187,903 shares during the last quarter. Finally, Worldquant Millennium Advisors LLC acquired a new stake in Humana during the 3rd quarter worth about $50,102,000. Institutional investors and hedge funds own 92.38% of the company’s stock.

Insider Activity

In other news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the transaction, the insider now directly owns 8,181 shares of the company’s stock, valued at $2,096,463.06. This represents a 31.16 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.32% of the company’s stock.

Humana Stock Up 0.2 %

Humana stock opened at $294.47 on Friday. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $406.46. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. The firm’s 50-day simple moving average is $274.39 and its 200 day simple moving average is $305.26. The stock has a market cap of $35.46 billion, a PE ratio of 26.08, a price-to-earnings-growth ratio of 2.15 and a beta of 0.55.

Humana (NYSE:HUM) last released its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.48 by $0.68. The company had revenue of $29.30 billion during the quarter, compared to analyst estimates of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. Research analysts predict that Humana Inc. will post 16.11 EPS for the current fiscal year.

Analysts Set New Price Targets

HUM has been the topic of several research analyst reports. KeyCorp assumed coverage on Humana in a research report on Friday, October 11th. They set a “sector weight” rating on the stock. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $395.00 price objective on shares of Humana in a research report on Tuesday, October 1st. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Humana from $349.00 to $250.00 and set a “hold” rating for the company in a research note on Thursday, October 3rd. Stephens reissued an “equal weight” rating and set a $250.00 target price on shares of Humana in a research note on Wednesday, October 9th. Finally, Truist Financial upped their price objective on shares of Humana from $260.00 to $290.00 and gave the company a “hold” rating in a report on Monday, January 6th. Twenty analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $302.80.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.